How DocuSign Did It Again With Q3 Earnings
DocuSign shares rose after it released better than expected fiscal third-quarter financial results late on Thursday.
All Work
Chris Lange
Ulta Beauty Q3 Earnings Make a Big Impression
Ulta Beauty shares popped after it released better than expected fiscal third-quarter financial results late Thursday.
Is Michaels in Trouble After Q3 Earnings?
Shares of Michaels pulled back after the arts and crafts chain released disappointing quarterly results and guidance early Thursday.
Thursday’s Biggest Biotech Movers
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Will These Q3 Earnings Put Kroger Back on Track?
Kroger shares retreated after it reported disappointing fiscal third-quarter financial results before the opening bell Thursday.
Should Dollar General Get More Credit for Q3 Earnings?
Dollar General reported better-than-expected fiscal third-quarter financial results before the markets opened on Thursday morning.
What to Expect When Kroger Reports Before the Opening Bell
Kroger is set to report its most recent quarterly results before the opening bell on Thursday. The consensus estimates are calling for $0.48 in earnings per share (EPS) and $28.2 billion in revenue. The…
What to Expect When Dollar General Reports Thursday
Dollar General is scheduled to release its fiscal third-quarter financial results before the markets open on Thursday.
Why This Transfusion-Dependent Beta-Thalassemia Trial Is Taking Off
Protagonist Therapeutics shares jumped on Wednesday after the company announced preliminary results from its midstage study for patients with transfusion-dependent beta-thalassemia.
Are Analysts Too Optimistic on Salesforce After Earnings?
Salesforce released fiscal third-quarter financial results after markets closed Thursday. Although investors sent shares lower in the wake of this report, analysts seem to have taken a different tact and are cheering these results.
Will These Record Black Friday Sales Get GoPro Back on Track?
GoPro shares popped on Wednesday after the firm announced strong sales results over the Thanksgiving weekend and Cyber Monday.
Campbell Soup Slides By With Q1 Earnings
Campbell Soup shares retreated after it released mixed fiscal first-quarter financial results before the markets opened on Friday.
Are Salesforce Q3 Earnings Enough For Investors?
Salesforce released its fiscal third-quarter financial results after the markets closed on Thursday. The firm said that it had $0.75 in earnings per share (EPS) and $4.5 billion in revenue, compared with consensus estimates…
Bill.com Announces Potential Pricing for IPO
Bill.com expects to price less than 9 million shares to result in an initial public offering valued up to more than $182 million.
What to Expect When Campbell Soup Reports Wednesday Morning
Campbell Soup is scheduled to release its most recent quarterly results before the markets open on Friday.
Are Audentes Shareholders Getting Enough in the Acquisition?
Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although Audentes has only been public for just over three years, this acquisition offers a…
How Aslan Pharma Is Capitalizing on Its Huge Atopic Dermatitis Success
Aslan Pharmaceuticals has been on a roller coaster for the past two weeks. Now the stock is coming back to earth, with the company announcing that it will be capitalizing on these gains with…
What to Expect When Zscaler Reports After the Close
Zscaler is scheduled to release its fiscal first-quarter results after the markets close on Tuesday, and analysts are looking for strong topline growth from last year.
Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.
Why Investors Shouldn’t Sleep on This Narcolepsy Study
Axsome Therapeutics shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial.